Investing in Growth, Enabling Change
English      中文

Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.

News

Arsenal Capital Acquires Specialty Contact Research Organization Synchrogenix and Merges with Certara

Purchase adds global regulatory writing and submission services to Certara's drug development consulting expertise

New York, NY – April 15, 2014 –Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Synchrogenix the leading regulatory writing and related services firm.  Synchrogenix provides services to pharmaceutical, biotechnology, and medical device companies worldwide.  Concurrent with the transaction, Synchrogenix will be merged into Certara™, a global technology-enabled drug development and drug safety consultancy...

Arsenal Capital Partners Announces Acquisition of Kel-Tech

Acquisition Broadens Arsenal's Exposure to Energy Sector

NEW YORK, March 10, 2014 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, announced today the acquisition of Kel-Tech, Inc., a leading specialty oilfield chemicals provider in the Permian basin.

Founded in 1983, and headquartered in Midland, Texas, Kel-Tech provides specialty chemicals and related services to production, field stimulation and drilling operations in the Oil & Gas market.  The company also provides technical and lab services to support ongoing needs of...

Arsenal Capital Partners Announces Acquisition of Danlin Industries

Danlin and Kel-Tech Inc. to Form a Leading North American Oil & Gas Solutions Platform

NEW YORK, March 10, 2014 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, announced today the acquisition of Danlin Industries from Hastings Equity Partners.

Headquartered in Thomas, Oklahoma, Danlin provides production chemicals, capillary services and completion chemical solutions to oil & gas exploration and production companies across Oklahoma, Texas, Wyoming, Arkansas, Louisiana, Colorado, New Mexico, Kansas and Utah.

On March 10, 2014, Arsenal Capital also...

Arsenal Capital Partners Names Frank Scrudato Chief Financial Officer

NEW YORK, February 13, 2014 - Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrial and healthcare companies, announced today the appointment of Frank Scrudato as Chief Financial Officer and Chief Compliance Officer.

Mr. Scrudato was formerly Chief Financial Officer and Principal of Bruckmann, Rosser, Sherrill & Co. (“BRS”).  Prior to BRS, he was a Director in the Transaction Services practices of KPMG and Arthur Andersen.  Mr. Scrudato also worked as the Director of...

FrontStream Holdings, LLC Acquires TRUiST, Expands Corporate Philanthropy Platform

FrontStream continues to grow their suite of solutions serving the nonprofit market with the addition of TRUiST's corporate giving tools

Reston, VA – February 28, 2014 – FrontStream Holdings, LLC (dba FrontStream Payments) has announced the addition of TRUiST, Inc. to their growing portfolio of brands. TRUiST is a leading provider of corporate philanthropy solutions based in Washington, DC.

The acquisition of TRUiST signifies another major step FrontStream has taken to further diversify their suite of tools that serve nonprofit organizations and those that support charitable causes. Last year, FrontStream announced the

Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara

NEW YORK,  December 19, 2013 - Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today the acquisition of Certara, the leading provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market.

Certara provides highly specialized and integrated solutions which consist of computer-based models supported by leading scientific consulting services and which span the...

Mouse over text to stop rotation
Copyright © 2005 - 2014 Arsenal Capital Partners. All rights reserved.